Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Sales (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Return on Sales for 9 consecutive years, with 68.57% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales fell 6249.0% year-over-year to 68.57%; the TTM value through Mar 2026 reached 3.55%, down 264.0%, while the annual FY2025 figure was 3.11%, 341.0% down from the prior year.
  • Return on Sales hit 68.57% in Q1 2026 for Bicycle Therapeutics, down from 0.56% in the prior quarter.
  • Across five years, Return on Sales topped out at 34.46% in Q4 2024 and bottomed at 68.57% in Q1 2026.
  • Average Return on Sales over 5 years is 9.01%, with a median of 6.09% recorded in 2025.
  • Year-over-year, Return on Sales soared 4439bps in 2024 and then plummeted -6249bps in 2026.
  • Bicycle Therapeutics' Return on Sales stood at 3.81% in 2022, then tumbled by -160bps to 9.93% in 2023, then skyrocketed by 447bps to 34.46% in 2024, then tumbled by -102bps to 0.56% in 2025, then crashed by -12148bps to 68.57% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 68.57%, 0.56%, and 5.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.